Patients with systemic inflammatory disorders, such as rheumatoid arthritis, and a concurrent Zn shortage have been demonstrated to have higher levels of IL-1α, IL-1β, and IL-6 expression compared to those who consume more Zn [76, 77]. The gene discussed is IL1B; the disease is rheumatoid arthritis.